Dementia drug development guidelines - Live telecast
Source: F-D-C Reports, Inc.
On March 9, 2000, FDA's Psychopharmacologic Drugs Advisory Committee will discuss drug development for Alzheimer's and other dementias.
On March 9, 2000, FDA's Psychopharmacologic Drugs Advisory Committee will discuss drug development for Alzheimer's and other dementias. The panel will address the problem of how to identify, define, and name clinical entities that fall under the dementia category in order to prevent misleading labeling.
The committee's deliberations will be televised live by videoconferencing, webcast and telephone link ups. In addition, videotapes will be available shortly after the meeting.
For information on how to receive the live telecast, use the Request Free Product Information online form above or contact:
F-D-C Reports, Inc., 5550 Friendship Blvd., Suite One, Chevy Chase, Maryland, 20815. Tel: 301-664-7210; Fax: 301-664-7245.
This website uses cookies to ensure you get the best experience on our website. Learn more